Archive | News/Press Release RSS feed for this section

Mvasi by Amgen is the First FDA Approved Cancer Biosimilar

FDA Approves the First Cancer Biosimilar Mvasi by Amgen is Hitting the US Market   Yesterday the FDA announced that Amgens biosimilar to Avastin, known as Mvasi (bevacizumab-awwb) was approved for five different types of cancer: Non-squamous non-small cell lung cancer (NSCLC) – in combination with chemotherapy Metastatic colorectal cancer (mCRC) – in combination with chemotherapy Glioblastoma Metastatic renal […]

Kelly Scientific Winner of Network Kildare Business Award

Deirdre Kelly PhD, was announced Emerging Business Woman of the Year 2017 by Network Kildare at Palmerstown House Estate last Friday evening.   Presented with the award by Minister of Jobs, Enterprise and Innovation, Mary Mitchell-O’Connor and President of Network Kildare Pauline Forde, Deirdre announced ‘it is a privilege and honor to receive such a prestigious […]

Regenerative Medicine Market to Hit $53 billion by 2021 – How Will the Trump Administration Impact its Growth?

Leading market analysts at Kelly Scientific indicate that the current regenerative medicine market is worth $18.9 billion globally, and will hit over $53 billion by 2021. Managing Director, Deirdre Kelly PhD announced, ‘the stem cell and tissue engineering sectors are currently driving this market at a strong CAGR of 23.3% over the next five years, […]

Meet us at FACE London June 2016

We are excited to present at FACE London this year, held at the QEII Centre, Westminster London from 15th-18th June. Dr Kelly will open the Business Agenda on Friday morning at 9:30am with a talk entitled “Vertical growth on a global scale: how cosmeceuticals and disruptive tech are driving the market” She will present new […]

Inflectra (infliximab-dyyb), 2nd Biosimilar Approved in US

The Biosimilar market got a significant boost this week as the FDA approved Inflectra (infliximab-dyyb) which is a biosimilar to Janssen Biotech’s Remicade (infliximab) on April 5th 2016. Celltrion manufactures Inflectra for Hospira, and is now approved for the following indications in the US: Crohn’s disease Ulcerative colitis Rheumatoid arthritis in combination with methotrexate Ankylosing spondylitis […]

Meet the Experts at IMCAS Paris 2016

IMCAS World Congress 2016 January 28th to 31st, Paris Meet Deirdre Kelly, PhD at IMCAS where the newest advancements in aesthetic surgery & cosmetic dermatology will be discussed. The highly exciting cosmeceutical market will also be a key area that is presented. Among the presentations, Deirdre is particularly interested in the following events: M&A dynamics and […]

1st Frontiers in IL-17 Meeting – Trinity College and Novartis

Meet Deirdre at the 1st Frontiers in IL-17 meeting held at the Science Gallery, Trinity College Dublin on Sept 4th 2015. In partnership with Novartis, this symposium aims to tackle the therapeutic potential of IL-17 signalling targets in autoimmune disorders such as Psoriasis, Crohn’s Disease and Rheumatoid Arthritis. There is a significant economic and patient burden […]

PRESS RELEASE: Cutting-edge new research by KellySciPub indicates that the core personalized medicine market will be worth over $60 billion by 2019.

  Cutting-edge new research by KellySciPub indicates that the core personalized medicine market will be worth over $60 billion by 2019. This market is made up of companion diagnostics and targeted therapeutics and is currently worth $42 billion. This market is dominated by oncology, cardiovascular and infectious disease treatment and diagnostics. The report ‘Personalized Medicine, […]